Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.

Abstract: A method for analyzing and classifying electronic documents. The method comprises steps of fetching an electronic document from an electronic document folder, wherein the electronic document comprises a plurality of key words. Then, the key words are retrieved. Further, according to an appearance frequency of each key word, a correlation between each two key words is calculated. Further, according to the correlations between the key words, the key words are classified into at least one technology group. Finally, the documents in the document folder are classified into at least one document group.

Abstract: MH15 (Hn1L) is identified as an oncogene. Methods and compositions for detecting and diagnosing cancer in patients are provided, by determining the level of MH15 expression in biological samples. Also provided are methods for screening for inhibitors and moderators of MH15 expression and activity, as well as compositions comprising compounds and molecules that inhibit or moderate MH15 expression or activity, thereby treating cancer, in vivo.

Abstract: Novel Mucroslysin protein and nucleic acid molecules are disclosed. The invention provides purified Mucroslysin protein, fusion protein, antigenic peptides, and anti-Mucroslysin antibodies. The invention also provides isolated Mucroslysin nucleic acid molecule, recombinant vectors containing the Mucroslysin nucleic acid molecule, host cells containng the recombinant vector, and non-human transgenic animals in which the Mucroslysin nucleic acid molecule has been introduced.